194 related articles for article (PubMed ID: 11567220)
1. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung.
Sturm N; Lantuéjoul S; Laverrière MH; Papotti M; Brichon PY; Brambilla C; Brambilla E
Hum Pathol; 2001 Sep; 32(9):918-25. PubMed ID: 11567220
[TBL] [Abstract][Full Text] [Related]
2. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
[TBL] [Abstract][Full Text] [Related]
3. Significant high expression of cytokeratins 7, 8, 18, 19 in pulmonary large cell neuroendocrine carcinomas, compared to small cell lung carcinomas.
Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Ryuge S; Masuda N; Jiang SX; Okayasu I
Pathol Int; 2010 Feb; 60(2):71-7. PubMed ID: 20398190
[TBL] [Abstract][Full Text] [Related]
4. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features.
Crapanzano JP; Loukeris K; Borczuk AC; Saqi A
Diagn Cytopathol; 2011 Feb; 39(2):92-100. PubMed ID: 21254456
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic issues with cytopathologic interpretation of lung neoplasms displaying high-grade basaloid or neuroendocrine morphology.
Maleki Z
Diagn Cytopathol; 2011 Mar; 39(3):159-67. PubMed ID: 21319315
[TBL] [Abstract][Full Text] [Related]
7. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
8. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.
Serrano MF; El-Mofty SK; Gnepp DR; Lewis JS
Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937
[TBL] [Abstract][Full Text] [Related]
9. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.
Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K
Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
11. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.
Agoff SN; Lamps LW; Philip AT; Amin MB; Schmidt RA; True LD; Folpe AL
Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334
[TBL] [Abstract][Full Text] [Related]
12. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma.
Peng WX; Sano T; Oyama T; Kawashima O; Nakajima T
Lung Cancer; 2005 Feb; 47(2):225-33. PubMed ID: 15639721
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
[TBL] [Abstract][Full Text] [Related]
14. Imprint cytologic features of pulmonary large cell neuroendocrine carcinoma: Comparison with classic large cell carcinoma.
Iyoda A; Baba M; Hiroshima K; Saitoh H; Moriya Y; Shibuya K; Iizasa T; Horiuchi F; Ohwada H; Fujisawa T
Oncol Rep; 2004 Feb; 11(2):285-8. PubMed ID: 14719055
[TBL] [Abstract][Full Text] [Related]
15. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
Zamecnik J; Kodet R
Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.
Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH
Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
[TBL] [Abstract][Full Text] [Related]
18. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
Chang YL; Lee YC; Liao WY; Wu CT
Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
[TBL] [Abstract][Full Text] [Related]
19. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
[TBL] [Abstract][Full Text] [Related]
20. Large cell neuroendocrine carcinoma of the tongue base: case report of an unusual location with immunohistochemical analysis.
Kusafuka K; Asano R; Kamijo T; Iida Y; Onitsuka T; Kameya T; Nakajima T
Int J Oral Maxillofac Surg; 2009 Mar; 38(3):296-9. PubMed ID: 19167190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
